10 verified backers on Callio Therapeutics's cap table, including Frazier Life Sciences, Jeito Capital, Novo Holdings A/S — Biotech (Seattle, United States).
Callio Therapeutics's investor syndicate for 2026, drawn from verified round records: 10 distinct firms and angels appear on the cap table, including Frazier Life Sciences, Jeito Capital, Novo Holdings A/S, Omega Funds, ClavystBio, Platanus. Callio Therapeutics is tracked in Biotech and headquartered in Seattle, United States.
The companies listed below are ranked by how much of that syndicate they share, so the overlap you see is backer-based rather than sector-based. Every investor name links to that firm's own profile with its full tracked portfolio, and every company links to its funding record.